Montenegro skin test and age of skin lesion as predictors of treatment failure in cutaneous leishmaniasis (Q34229998)

31 July 2017

title

Montenegro skin test and age of skin lesion as predictors of treatment failure in cutaneous leishmaniasis (English)

1 reference

ORCID Public Data File 2021

31 July 2017

1 reference

author name string

Liliane de Fátima Antonio

1

1 reference

31 July 2017

Aline Fagundes

2

1 reference

31 July 2017

Raquel Vasconcellos Carvalhaes Oliveira

3

1 reference

31 July 2017

Priscila Garcia Pinto

4

1 reference

31 July 2017

Sandro Javier Bedoya-Pacheco

5

1 reference

31 July 2017

Erica de Camargo Ferreira e Vasconcellos

6

1 reference

31 July 2017

Maria Cláudia Valete-Rosalino

7

1 reference

31 July 2017

Marcelo Rosandiski Lyra

8

1 reference

31 July 2017

Sônia Regina Lambert Passos

9

1 reference

31 July 2017

Maria Inês Fernandes Pimentel

10

1 reference

31 July 2017

Armando de Oliveira Schubach

11

1 reference

31 July 2017

publication date

1 September 2014

1 reference

31 July 2017

number of pages

6

1 reference

Revista do Instituto de Medicina Tropical de São Paulo

inferred from page(s)

published in

1 reference

31 July 2017

volume

56

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

375-380

1 reference

Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World.

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172107

Epidemiological and clinical characteristics of cutaneous leishmaniasis and their relationship with the laboratory data, south of Brazil.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172107

Association of treatment of American cutaneous leishmaniasis prior to ulcer development with high rate of failure in northeastern Brazil

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172107

Failure of both azithromycin and antimony to treat cutaneous leishmaniasis in Manaus, AM, Brazil

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172107

The predictive validity of naturally acquired delayed-type hypersensitivity to leishmanin in resistance to Leishmania major-associated cutaneous leishmaniasis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172107

Up-regulation of Th1-type responses in mucosal leishmaniasis patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172107

American cutaneous leishmaniasis: use of a skin test as a predictor of relapse after treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172107

American tegumentary leishmaniasis (ATL) in Rio de Janeiro State, Brazil: main clinical and epidemiologic characteristics

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172107

Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172107

Cytokine patterns in the pathogenesis of human leishmaniasis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172107

Leishmanin skin test standardization and evaluation of safety, dose, storage, longevity of reaction and sensitization.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172107

Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer

6 July 2018

1 reference

https://api.crossref.org/works/10.1590/S0036-46652014000500002

Clinical, epidemiological and laboratory aspects of patients with American cutaneous leishmaniasis in the State of Pernambuco

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/S0036-46652014000500002

Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/S0036-46652014000500002

Retrospective study of 151 patients with cutaneous leishmaniasis treated with meglumine antimoniate

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/S0036-46652014000500002

A rare case of leishmaniasis recidiva cutis evolving for 31 years caused by Leishmania tropica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/S0036-46652014000500002

Epidemiological profile of cutaneous leishmaniasis in an endemic region in the State of Rio de Janeiro, Brazil.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172107

Cytokine profile in Montenegro skin test of patients with localized cutaneous and mucocutaneous leishmaniasis

28 October 2018

1 reference

https://api.crossref.org/works/10.1590/S0036-46652014000500002

A randomized double-blind placebo-controlled trial to evaluate the immunogenicity of a candidate vaccine against American tegumentary leishmaniasis

21 January 2018

1 reference

12 December 2020

Treatment of American cutaneous leishmaniasis: a comparison between low dosage (5 mg/kg/day) and high dosage (20 mg/kg/day) antimony regimens

1 reference

12 December 2020

Comparative assessment of the efficacy and toxicity of N-methyl-glucamine and BP88 sodium stibogluconate in the treatment of localized cutaneous leishmaniasis

1 reference

12 December 2020

A Low-Dose Antimony Treatment in 159 Patients with American Cutaneous Leishmaniasis: Extensive Follow-up Studies (Up to 10 Years)

1 reference

12 December 2020

[American cutaneous leishmaniasis]

1 reference

12 December 2020

Standardization of the Montenegro antigen

1 reference

12 December 2020

[Factors associated with treatment failure of cutaneous leishmaniasis with meglumine antimoniate]

1 reference

12 December 2020

Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis

1 reference

12 December 2020

Sensitivity of leishmanin skin test in patients of acute cutaneous leishmaniasis

1 reference

12 December 2020

A STUDY OF VARIABILITY IN TUBERCULIN TEST READING

1 reference

12 December 2020

10.1590/S0036-46652014000500002

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference